|
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |  |
SEPTEMBER 25, 2006
Green-Lighting Walgreen  When the market gets choppy, go for the proven long-haul winners. So counsels Michael Schwartzman, president of ValueSearch Capital Management, who singles out Walgreen (WAG
) (WAG), the No. 1 U.S. drugstore chain, as a prime example. Walgreen, in which ValueSearch owns shares, is "well managed, with a conservative approach to accounting," and has avoided sorry surprises and earnings restatements, Schwartzman says. Since May its stock has shot from 39 to 49.31. In four years he sees it at 93 based on his earnings growth forecast. Walgreen operates 5,200 stores in 45 states and Puerto Rico. It was featured here on July 10, 2001, when it was at 29. Schwartzman is confident about the predictability of its earnings because they are driven by organic growth, not high-priced acquisitions that usually bring heavy debt. Walgreen's few buys, he notes, have been small independent chains that lacked the resources to battle with big rivals. Walgreen's prescription and non-pharmacy sales growth in 2005 beat those of the industry, notes Standard & Poor's, (MHP
) which rates it a "buy." Neil Currie of UBS (UBS
), who also pegs Walgreen as a "buy," forecasts above-consensus earnings of $1.74 a share on sales of $46.9 billion for fiscal 2006 ended Aug. 31. He says: "Walgreen deserves to be a core long-term holding." For 2007, Currie sees earnings of $2.01 on sales of $53 billion. Last year, Walgreen earned $1.54 on $42.2 billion. Currie's 12-month price target: 60.
Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them.  By Gene G. Marcial
BW MALL
SPONSORED LINKS
Get BusinessWeek directly on your desktop with our RSS feeds.
Buy a link now! Add BusinessWeek news to your Web site with our headline feed. Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video. To subscribe online to BusinessWeek magazine, please click here. Learn more, go to the BusinessWeekOnline home page  | | |
 Copyright 2006, by The McGraw-Hill Companies Inc. All rights reserved.Terms of Use | Privacy Notice |
Printer-Friendly Version